IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Piotroski F-Score: 7 (As of Jun. 25, 2026) — Near Median


NSE:IOLCP IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
68 GF Score
Price ₹133.66
GF Value ₹93.62
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is IOL Chemicals And Pharmaceuticals Piotroski F-Score?

IOL Chemicals And Pharmaceuticals NSE:IOLCP +2.06% 68 Piotroski F-Score is 7 as of Jun. 25, 2026, which is at its 10-year median of 7.00. GuruFocus rates NSE:IOLCP with a GF Score™ of 68/100 and a GF Value™ of ₹93.62 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 981 Drug Manufacturers companies, IOL Chemicals And Pharmaceuticals ranks better than 91.85% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

IOL Chemicals And Pharmaceuticals has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for IOL Chemicals And Pharmaceuticals's Piotroski F-Score or its related term are showing as below:

NSE:IOLCP' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 7   Max: 8
Current: 7

During the past 13 years, the highest Piotroski F-Score of IOL Chemicals And Pharmaceuticals was 8. The lowest was 3. And the median was 7.

IOL Chemicals And Pharmaceuticals  (NSE:IOLCP) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


IOL Chemicals And Pharmaceuticals Piotroski F-Score Related Terms


IOL Chemicals And Pharmaceuticals Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for IOL Chemicals And Pharmaceuticals's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IOL Chemicals And Pharmaceuticals Piotroski F-Score Chart

IOL Chemicals And Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 5.00 6.00 5.00 7.00

IOL Chemicals And Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 0.00 0.00 0.00 7.00

NSE:IOLCP vs ZTS: Piotroski F-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IOL Chemicals And Pharmaceuticals Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where IOL Chemicals And Pharmaceuticals's Piotroski F-Score falls into.


NSE:IOLCP
68GF Score
IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was ₹1,376 Mil.
Cash Flow from Operations was ₹2,143 Mil.
Revenue was ₹23,191 Mil.
Gross Profit was ₹8,320 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (23820.7 + 25869.5) / 2 = ₹24845.1 Mil.
Total Assets at the begining of this year (Mar25) was ₹23,821 Mil.
Long-Term Debt & Capital Lease Obligation was ₹24 Mil.
Total Current Assets was ₹12,276 Mil.
Total Current Liabilities was ₹6,902 Mil.
Net Income was ₹1,011 Mil.

Revenue was ₹20,792 Mil.
Gross Profit was ₹6,874 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (22444 + 23820.7) / 2 = ₹23132.35 Mil.
Total Assets at the begining of last year (Mar24) was ₹22,444 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0 Mil.
Total Current Assets was ₹11,513 Mil.
Total Current Liabilities was ₹6,099 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

IOL Chemicals And Pharmaceuticals's current Net Income (TTM) was 1,376. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

IOL Chemicals And Pharmaceuticals's current Cash Flow from Operations (TTM) was 2,143. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=1376.4/23820.7
=0.05778168

ROA (Last Year)=Net Income/Total Assets (Mar24)
=1010.7/22444
=0.04503208

IOL Chemicals And Pharmaceuticals's return on assets of this year was 0.05778168. IOL Chemicals And Pharmaceuticals's return on assets of last year was 0.04503208. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

IOL Chemicals And Pharmaceuticals's current Net Income (TTM) was 1,376. IOL Chemicals And Pharmaceuticals's current Cash Flow from Operations (TTM) was 2,143. ==> 2,143 > 1,376 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=24/24845.1
=0.00096599

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=0/23132.35
=0

IOL Chemicals And Pharmaceuticals's gearing of this year was 0.00096599. IOL Chemicals And Pharmaceuticals's gearing of last year was 0. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=12276.3/6901.8
=1.7787099

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=11513.4/6099.1
=1.88772114

IOL Chemicals And Pharmaceuticals's current ratio of this year was 1.7787099. IOL Chemicals And Pharmaceuticals's current ratio of last year was 1.88772114. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

IOL Chemicals And Pharmaceuticals's number of shares in issue this year was 293.475. IOL Chemicals And Pharmaceuticals's number of shares in issue last year was 293.808. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=8319.8/23190.6
=0.35875743

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=6873.6/20792.1
=0.3305871

IOL Chemicals And Pharmaceuticals's gross margin of this year was 0.35875743. IOL Chemicals And Pharmaceuticals's gross margin of last year was 0.3305871. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=23190.6/23820.7
=0.97354822

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=20792.1/22444
=0.92639904

IOL Chemicals And Pharmaceuticals's asset turnover of this year was 0.97354822. IOL Chemicals And Pharmaceuticals's asset turnover of last year was 0.92639904. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+0+1+1+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

IOL Chemicals And Pharmaceuticals has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a Piotroski F-Score of 7 as of Jun. 25, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. This is near median its historical median of 7.00. Over the past decade, IOL Chemicals And Pharmaceuticals' Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #80 out of 981 companies in the Drug Manufacturers industry, placing it in the top 8.2%.
Is IOL Chemicals And Pharmaceuticals' Piotroski F-Score too high?
IOL Chemicals And Pharmaceuticals' current Piotroski F-Score of 7 is near median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. IOL Chemicals And Pharmaceuticals' value of 7 is 40% above this industry median. Based on the distribution chart, IOL Chemicals And Pharmaceuticals ranks #80 out of 981 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' Piotroski F-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #80 out of 981 companies for Piotroski F-Score. This places IOL Chemicals And Pharmaceuticals in the top 8% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. IOL Chemicals And Pharmaceuticals' value of 7 is 40% above this benchmark. Historically, IOL Chemicals And Pharmaceuticals' own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 7.00 vs. the industry median of 5.00, IOL Chemicals And Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 981 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IOL Chemicals And Pharmaceuticals's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IOL Chemicals And Pharmaceuticals's current Piotroski F-Score is 7, which is near median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹93.62, compared to a current price of ₹133.66 — trading 42.8% above its estimated fair value. The current Piotroski F-Score is 7, which is near median its 10-year median of 7.00 and 40% above the Drug Manufacturers industry median of 5.00. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current Piotroski F-Score is 7 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?

Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued. The current stock price of ₹133.66 is trading 42.8% above its estimated GF Value™ of ₹93.62. GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:IOLCP:

  • Piotroski F-Score: 7 (near median its 10-year median of 7.00)
  • GF Value™: ₹93.62 vs. price of ₹133.66 (42.8% above fair value)
  • GF Score™: 68/100 with 5 warning signs
  • Industry Position: 40% above the Drug Manufacturers median (#80 of 981)

No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IOL Chemicals And Pharmaceuticals Business Description

Other Exchanges 524164:India
Address 85, Industrial Area, A, Ludhiana, PB, IND, 141 003
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
68GF Score

Get the complete analysis for NSE:IOLCP

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹133.66
Price
₹93.62
GF Value